Mapping the surface of pancreatic cancer cells

Identifying proteins on pancreatic cancer cells that could become new targets for developing future treatments.
Picture: Professor Tracy Putoczki, Laboratory Head at WEHI

Mapping the surface of pancreatic cancer cells

July 1, 2026
Identifying proteins on pancreatic cancer cells that could become new targets for developing future treatments.
Read Transcript

The challenge 

Pancreatic cancer remains one of the deadliest cancers in Australia. It is the third most common cause of cancer-related death, with an incidence rate of 14 cases per 100,000 people. It is particularly difficult to treat because it is often diagnosed at an advanced stage, leaving patients with limited treatment options. Fewer than 14% of people diagnosed with pancreatic cancer survive beyond five years.

Cancer affects us all. Many of us have lost family, friends or colleagues to this disease. For Professor Tracy Putoczki and her team at WEHI, their response is to use research and discovery to help create new possibilities for patients. The team is exploring the unique characteristics of pancreatic cancer cells, focusing on the proteins found on their surface. Understanding these proteins could reveal new insights into how pancreatic cancer develops and identify potential opportunities for future treatments.

What this could unlock

Hearts & Minds funding, as nominated by Cooper Investors, has enabled Professor Putoczki’s team to pursue ambitious discovery research that could uncover new approaches to treating pancreatic cancer. This includes building the tools, creating the datasets and bringing together the collaborations needed to translate laboratory findings into real-world impact.

By mapping the surface of pancreatic cancer cells, the researchers aim to identify proteins that could become druggable targets and form the foundation for future therapies. If the team identifies a novel drug target, the next steps will be to demonstrate that targeting it can change the behaviour of the cancer and, if successful, progress towards the drug development pipeline with the aim of developing future treatments for patients.

While this research is still in its early stages, building a deeper understanding of pancreatic cancer cells is an important first step towards uncovering new treatment opportunities. Ultimately, Professor Tracy Putoczki and her team want to move the dial on survivorship and give more people diagnosed with pancreatic cancer the opportunity to live longer, with a better quality of life.

This project is supported by Hearts and Minds Investments, as nominated by Cooper Investors. For further information and updates, visit WEHI.

The challenge 

Pancreatic cancer remains one of the deadliest cancers in Australia. It is the third most common cause of cancer-related death, with an incidence rate of 14 cases per 100,000 people. It is particularly difficult to treat because it is often diagnosed at an advanced stage, leaving patients with limited treatment options. Fewer than 14% of people diagnosed with pancreatic cancer survive beyond five years.

Cancer affects us all. Many of us have lost family, friends or colleagues to this disease. For Professor Tracy Putoczki and her team at WEHI, their response is to use research and discovery to help create new possibilities for patients. The team is exploring the unique characteristics of pancreatic cancer cells, focusing on the proteins found on their surface. Understanding these proteins could reveal new insights into how pancreatic cancer develops and identify potential opportunities for future treatments.

What this could unlock

Hearts & Minds funding, as nominated by Cooper Investors, has enabled Professor Putoczki’s team to pursue ambitious discovery research that could uncover new approaches to treating pancreatic cancer. This includes building the tools, creating the datasets and bringing together the collaborations needed to translate laboratory findings into real-world impact.

By mapping the surface of pancreatic cancer cells, the researchers aim to identify proteins that could become druggable targets and form the foundation for future therapies. If the team identifies a novel drug target, the next steps will be to demonstrate that targeting it can change the behaviour of the cancer and, if successful, progress towards the drug development pipeline with the aim of developing future treatments for patients.

While this research is still in its early stages, building a deeper understanding of pancreatic cancer cells is an important first step towards uncovering new treatment opportunities. Ultimately, Professor Tracy Putoczki and her team want to move the dial on survivorship and give more people diagnosed with pancreatic cancer the opportunity to live longer, with a better quality of life.

This project is supported by Hearts and Minds Investments, as nominated by Cooper Investors. For further information and updates, visit WEHI.

Disclaimer: This material has been prepared by Hearts & Minds, published on July 1, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
July 1, 2026

Improving care for adults with motor neuron diseases

Building better care for adults living with Motor Neuron Disease and Spinal Muscular Atrophy.

Read More
July 1, 2026

Understanding fatigue in young people with Charcot-Marie-Tooth disease

Developing a tool to improve understanding, research and care.

Read More
Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).
July 1, 2026

Giving families living with rare diseases the answers they need

Supporting research to improve the diagnosis of rare genetic neuromuscular diseases and build the foundations for future treatments.

Read More
Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher
July 1, 2026

Understanding spinal cord injury recovery

The world's first molecular map of spinal cord injury across time and injury levels

Read More
Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium
July 1, 2026

Building the foundations for faster progress against brain cancer

Uniting researchers, clinicians and patients to accelerate research and improve patient care.

Read More
July 1, 2026

Accelerating CAR-T cell therapies for patients in need 

Bringing innovative cancer therapies closer to patients.

Read More
July 1, 2026

Supporting babies at high risk of cerebral palsy from the very beginning

Testing a family-centred early intervention program to improve outcomes for infants and support parents during the first critical months of life.

Read More
July 1, 2026

Making early cerebral palsy screening more accessible

Exploring new ways to identify babies at risk of cerebral palsy sooner and support better outcomes.

Read More
Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI
July 1, 2026

Understanding how breast cancer begins

Tracking the earliest changes in BRCA mutation carriers to help prevent cancer before it starts.

Read More
July 1, 2026

A new path forward for women living with period and pelvic pain

Uncovering the biology driving debilitating symptoms

Read More
Picture: Professor Daniel MacArthurPicture: Professor Daniel MacArthurPicture: Professor Daniel MacArthurPicture: Professor Daniel MacArthur
July 1, 2026

Closing the gap in rare disease diagnosis for Australian families

Building better genomic tools and more representative data to help families receive answers sooner.

Read More
PICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her team
July 1, 2026

Developing a new mRNA vaccine for Alzheimer’s disease

Using innovative technology to explore new possibilities for treatment and prevention.

Read More
Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS.
July 1, 2026

Unlocking new approaches for Multiple Sclerosis

Understanding why the brain fails to repair itself and exploring new treatment possibilities.

Read More
July 1, 2026

Helping emergency doctors make faster decisions with AI

Using Australian-developed artificial intelligence to improve emergency care.

Read More
July 1, 2026

Protecting vulnerable children, when it matters most

How the Safer Kids Project is helping identify and protect children at risk in emergency care

Read More